6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow Streptococcus Pneumoniae: new trials by email Literature Review of Streptococcus Pneumoniae trials Research Report on Streptococcus Pneumoniae
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ Pneumococcal conjugate vaccine GSK 1024850A, Pneumococcal conjugate vaccine Prevenar™ (Wyeth Lederle's) - Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Completed | GlaxoSmithKline | 52 | 2009-06-23 | 2020-11-23 |
| Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease Pneumococcal conjugate vaccine GSK1024850A, GSK Biologicals' Engerix TM vaccine (Hepatitis B vaccine), GSK Biologicals' Havrix TM vaccine (Hepatitis A vaccine) - Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Completed | GlaxoSmithKline | 41188 | 2009-05-04 | 2020-12-17 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age Pneumococcal conjugate vaccine GSK1024850A, Tritanrix-HepB/Hib, Hiberix - Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Completed | GlaxoSmithKline | 360 | 2009-03-07 | 2020-01-03 |
| Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Pneumococcal conjugate vaccine Synflorix (GSK1024850A), GSK Biologicals' Engerix TM vaccine (Hepatitis B vaccine), GSK Biologicals' Havrix TM vaccine (Hepatitis A vaccine) - Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Completed | GlaxoSmithKline | 6181 | 2009-02-18 | 2020-12-17 |
| Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar Pneumo 23, Prevnar - Streptococcus Pneumoniae | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 339 | 2007-11-01 | 2015-06-18 |
| Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting pneumococcal conjugate vaccine, pneumococcal polysaccharide vaccine - HIV Infections, Streptococcus Pneumoniae | Phase 3 | Completed | Henry M. Jackson Foundation for the Advancement of Military Medicine | 275 | 2002-12-01 | 2025-06-08 |
Streptococcal Infections (4) · Haemophilus Infections (3) · Otitis Media (2) · HIV Infections (1) · Pneumococcal Infections (1) · Pneumonia (1) · Respiratory Tract Infections (1)
Infections (5) · Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Positive Bacterial Infections (4) · Gram-Negative Bacterial Infections (3) · Pasteurellaceae Infections (3) · Ear Diseases (2) · Otitis (2) · Otorhinolaryngologic Diseases (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Lentivirus Infections (1)
Hepatitis A Vaccines (2) · Hepatitis B Vaccines (2) · Heptavalent Pneumococcal Conjugate Vaccine (1) · Hiberix (1) · Pneumococcal Vaccines (1) · Tritanrix-HepB vaccine (1)
GlaxoSmithKline (4) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · Sanofi Pasteur, a Sanofi Company (1)
Finland (2) · Germany (1) · India (1) · Thailand (1) · United States (1)
Brian Agan, MD (1)
PMID 34986178, PMID 20795819, PMID 20887830, PMID 23158882, PMID 24287186, PMID 25008901, PMID 25127244, PMID 25424793, PMID 26284652, PMID 27125273, PMID 29503110, PMID 30145098, PMID 31122856
2008 (3)